Relative hyperhomocysteinemia in patients with panic disorder: A case-control study

Neuropsychobiology

Volumn 62, Issue 3, 2010, Pages 164-170

  Meier, Christian ^a   Harbrecht, Ursula ^a   Liedtke, Reinhard ^a   Oldenburg, Johannes ^a   Conrad, Rupert ^a   Imbierowicz, Katrin ^a   Klingmüller, Dietrich ^a   Geiser, Franziska ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Agoraphobia; Anxiety; Cardiovascular risk; Homocysteine; Psychological distress

Indexed keywords

HOMOCYSTEINE;

ADULT; AGORAPHOBIA; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PANIC; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; ADULT; AGED; AGORAPHOBIA; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 77954390746     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318573     Document Type: Article

References (59)

1. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-1050.
2. Mudd SH, Finkelstein JD, Irreverre F, Laster L: Homocystinuria: an enzymatic defect. Science 1964; 143: 1443-1445.
3. Boushey CJ, Beresford SA, Omen GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057.
4. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236.
5. Stanger O: Physiology of folic acid in health and disease. Curr Drug Metab 2002; 3: 211-223.
6. Graham I, Daly E: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775-1781.
7. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G: Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995; 274: 1526-1533.
8. Hemingway H, Marmot M: Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 1999; 318: 1460-1467.
9. Haines AP, Imeson JD, Meade TW: Phobic anxiety and ischemic heart disease. BMJ 1987; 295: 297-299.
10. Kawachi I, Sparrow D, Vokonas PS, Weiss ST: Symptoms of anxiety and risk of coronary heart disease. The normative aging study. Circulation 1994b;90: 2225-2229.
11. Fleet R, Lavoie K, Beitman BD: Is panic disorder associated with coronary artery disease? A critical review of the literature. J Psychosom Res 2000; 48: 347-356.
12. Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willet WC: Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89: 1992-1997.
13. Shen BJ, Avivi YE, Todaro JF, Spiro A 3rd, Laurenceau JP, Ward KD, Niaura R: Anxiety characteristics independently and prospectively predict myocardial infarction in men the unique contribution of anxiety among psychologic factors. J Am Coll Cardiol 2008; 51: 113-119.
14. Yeragani VK, Balon R, Pohl R, Ramesh C, Glitz D, Weinberg P, Merlos B: Decreased RR variance in panic disorder patients. Acta Psychiatr Scand 1990; 81: 554-559.
15. Yeragani VK, Pohl R, Berger R, Balon R, Ramesh C, Glitz D, Srinivasan K, Weinberg P: Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res 1993; 318: 1005-1012.
16. Kawachi I, Sparrow D, Vokonas PS, Weiss ST: Decreased heart rate variability in men with phobic anxiety (data from the Normative Aging Study). Am J Cardiol 1995;75: 882-885.
17. Kubzansky LD, Kawachi I, Weiss S, Sparrow D: Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med 1998;20: 47-58.
18. Freedman DS, Byers T, Barrett DH, Stroup NE, Eaker E, Monroe-Blum H: Plasma lipid and psychological characteristics in men. Am J Epidem 1995; 141: 507-517.
19. Geiser F, Meier C, Wegener I, Imbierowicz K, Conrad R, Liedtke R, Oldenburg J, Harbrecht U: Association between anxiety and factors of coagulation and fibrinolysis. Psychother Psychosom 2008; 77: 377-383.
20. Von Känel R, Kudielka BM, Schulze R, Gander M-L, Fischer JE: Hypercoagulability in working men and women with high levels of panic-like anxiety. Psychother Psychosom 2004; 73: 353-360.
21. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM: Folate, vitamin B 12 , homocysteine, and the MTHFR 677 C-T polymorphism in anxiety and depression. The Hordaland Homocysteine Study. Arch Gen Psychiatry 2003; 60: 618-626.
22. Tolmunen T, Hintikka J, Voutilainen S, Ruusunen A, Alfthan G, Nyyssönene K, Viinamäki H, Kaplan GA, Salonen JT: Association between depressive symptoms and serum concentrations of homocysteine in men: a population study. Am J Clin Nutr 2004; 80: 1574-1578.
23. Sachdev PS, Parslow RA, Lux O, Salonikas C, Wen W, Naidoo D, Christensen H, Jorm AF: Relationship of homocysteine, folic acid and vitamin B 12 with depression in a middleaged community sample. Psychol Med 2005; 35: 529-538.
24. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH: Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000; 69: 228-232.
25. Stoney CM: Plasma homocysteine levels increase in women during psychological stress. Life Sci 1999; 64: 2359-2365.
26. Sawai A, Ohshige K, Kura N, Tochikubo O: Influence of mental stress on the plasma homocysteine level and blood pressure change in young men. Clin Exp Hypertens 2008; 30: 223-241.
27. Stoney CM, Engebretson TO: Plasma homocysteine concentrations are positively associated with hostility and anger. Life Sci 2000; 66: 2267-2275.
28. Papageorgiou C, Pitsavos C, Panagiotakos DB, Kontoangelos K, Chrysohoou C, Papadimitriou GN, Rabavilas AD: Association between hostility and plasma total homocysteine concentration in a general population sample. Neuropsychobiology 2006; 53: 26-32.
29. Hapuarachchi JR, Chalmers AH, Winefield AH, Blake-Mortimer JS: Changes in clinically relevant metabolites with psychological stress parameters. Behav Med 2003; 29: 52-59.
30. Levine I, Timinsky I, Vishne T, Dwolatzky T, Roitman S, Kaplan Z, Koter M, Ami Sela B, Spivak B: Elevated serum homocysteine levels in male patients with PTSD. Depress Anxiety 2007; 25:E154-E157.
31. Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C: Anxiety in relation to inflammation and coagulation markers, among healthy adults: The ATTICA Study. Atherosclerosis 2006; 185: 320-326.
32. Wittchen HU, Zaudig M, Fydrich T: SKID. Structured clinical interview for DSM-IV: axis I and II (Strukturiertes Klinisches Interview für DSM-IV: Achse I und II). Göttingen, Hogrefe, 1997.
33. Klaghofer R, Brähler E: Construction and test statistics of a short form of SCL-90-R (Konstruktion und teststatistische Prüfung einer Kurzform der SCL-90-R). Z Klin Psychol 2001; 49: 115-124.
34. Derogatis LR: SCL-90-R: Administration, Scoring, and Procedures Manual-I for the R (Revised) Version of the Psychopathology Rating Scale Series. Baltimore, John Hopkins University School of Medicine, 1977.
35. Laux L, Glanzmann P, Schaffer P, Spielberger CD: The state-trait-anxiety- inventory (Das State-Trait-Angstinventar). Weinheim, Beltz Test, 1981.
36. Hautzinger M, Bailer M: The general depression scale (Die Allgemeine Depressions Skala). Göttingen, Hogrefe, 1993.
37. Schwenkmezger P, Hodapp V, Spielberger CD: The state-trait-anger- expression-inventory (STAXI - State-Trait-Ärgerausdrucks- Inventar). Bern, Huber, 1992.
38. Diekman MJ, Van Der Put NM, Blom HJ, Tijssen JG, Wiersinga WM: Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol (Oxf) 2001; 54: 197-204.
39. Liaugaudas G, Jaques PF, Selhub J, Rosenberg IH, Bostom AG: Renal insufficiency, vitamin B 12 status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid fortified cereal grain flour. Arterioscler Thromb Vasc Biol 2001; 21: 849-851.
40. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders - DSM-IV-TR, ed 4 rev. Washington, APA, 2000.
41. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
42. Dadds MR, Gaffney LR, Kenardy J, Oei TP, Evans L: An exploration of the relationship between expression of hostility and the anxiety disorders. J Psychiatr Res 1993; 27: 17-26.
43. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J: Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001; 73: 613-621.
44. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M: Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic disease. Z Kardiol 2004;93: 439-453.
45. Cowley DS: Alcohol abuse, substance abuse, and panic disorder. Am J Med 1992; 92: 41S- 48S.
46. Alcocer-Castillejos NV, Alejo-Galarza G: Nicotine dependence and psychiatric disorder. Rev Invest Clin 2003; 55: 677-693.
47. Bottiglieri T, Hyland K, Laundy M, Godfrey P, Carney MW, Toone BK, Reynolds EH: Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med 1992; 22: 871-876.
48. Bell IR, Edman JS, Selhub J, Morrow FD, Marby DW, Kayne HL, Cole JO: Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 1992; 86: 386-390.
49. Sachdev PS, Valenzuela MJ, Brodaty H, Wang XL, Looi J, Lorentz L, Howard L, Jones M, Zagami AS, Gillies D, Wilcken DE: Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement Geriatr Cogn Disord 2003; 15: 155-162.
50. Bisschops RH, Van Der Graaf Y, Mali WP, Van Der Grond J: Elevated levels of plasma homocysteine are associated with neurotoxicity. Atherosclerosis 2004; 174: 87-92.
51. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP: Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000; 20: 6920-6926.
52. Sachdev P: Homocysteine and neuropsychiatric disorders (in Portuguese). Rev Bras Psiquiatr 2004; 26: 50-56.
53. Ballenger JC: Comorbidity of panic and depression: implications for clinical management. Int Clin Psychopharmacol 1998; 13 (suppl 4):S13-S17.
54. Bleich S, Bleich K, Kropp S, Bittermann HJ, Degner D, Sperling W, Rüther E, Kornhuber J: Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the 'French paradox'? Alcohol Alcohol 2001; 36: 189-192.
55. Ubbink JB, Vermaak WJ, Van Der Merwe A, Becker PJ: The effect of blood sample aging and food consumption on plasma total homocysteine levels. Clin Chim Acta 1992; 207: 119-128.
56. Guttormsen AB, Schneede J, Fiskerstrand T, Ueland PM, Refsum HM: Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 1994; 124: 1934-1941.
57. Fokkema MR, Gilissen MF, van Doormaal JJ, Volmer M, Kema IP, Muskiet FAJ: Fasting vs. nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia. Clin Chem 2003; 49: 818-821.
58. Thirup P, Ekelund S: Day-to-day, postprandial, and orthostatic variation of total plasma homocysteine. Clin Chem 1999; 45: 1280-1283.
59. Donnelly JG, Isotalo PA: Non-fasting reference intervals for the Abbott IMx homocysteine and AxSYM plasma folate assay: influence of the methylentetrahydrofolate reductase 677C-T mutation on homocysteine. Ann Clin Biochem 2000; 37: 390-398.